Role of Insulin-Like Growth Factor-1 in Colon Cancerogenesis: A Case-Control Study

Archives of Medical Research

Volumn 38, Issue 5, 2007, Pages 519-525

  Tripkovic, Ingrid ^a   Tripkovic, Andro ^b   Strnad, Marija ^c   Capkun, Vesna ^d   Zekan, Ljubinka ^d  

^a Pub Hlth Inst Split Dalmatia Co   (Croatia)

^b Department of Surgery ^*  (Croatia)

^c CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^d UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Cancer risk; Colon cancer; IGF 1

Indexed keywords

C PEPTIDE; GROWTH HORMONE; INSULIN; SOMATOMEDIN C;

ARTICLE; BLOOD ANALYSIS; CANCER PATIENT; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34249896702     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.01.012     Document Type: Article

References (29)

1. Pollak M. Insulin-like growth factor physiology and cancer risk. Eur J Cancer 36 (2000) 1224-1228
2. Moschos S.J., and Mantzoros C.S. The role of the IGF system in cancer: from basic to clinical studies and clinical studies and clinical applications. Oncology 63 (2002) 317-332
3. Pollak M.N., Perdue J.F., Margolese R.G., Bear K., and Richard M. Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett 38 (1987) 223-230
4. Guo Y.S., Narayan S., Yallampalli C., and Singh P. Characterization of insulin-like growth factor 1 receptors in human colon cancer. Gastroenterology 102 (1992) 1101-1108
5. Watkins L., Lewis L., and Levine A. Characterization of the synergistic effect of insulin and transferring and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 45 (1990) 372-375
6. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131 (2001) 3109S-3120S
7. MacDonald R.S., Thornton W.H., and Bean T.L. Insulin and IGF-1 receptors in a human intestinal adenocarcinoma cell line (Caco-2) regulation of Na+ glucose transport across the brush border. J Recept Res 13 (1993) 1093-1113
8. Macaulay V.M. Insulin-like growth factors and cancer. Br J Cancer 65 (1992) 311-320
9. Soos M.A., Whittaker J., Lammers R., Ullrich A., and Siddle K. Receptors for insulin and insulin-like growth factor-1 can form hybrid dymers. Characterisation of hybrid receptors in transfected cells. Biochem J 270 (1990) 383-390
10. Bach L.A., and Rechler M.M. Insulin-like growth factors and diabetes. Diabetes Metab Res Rev 8 (1992) 229-257
11. Flier J.S., Usher P., and Moses A.C. Monoclonal antibody to the type 1 insulin-like growth factor (IGF-1) receptor blocks IGF-1 receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-1 and insulin in human skin fibroblasts. Proc Natl Acad Sci USA 83 (1986) 664-668
12. Moller D.E., and Flier J.S. Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 325 (1991) 938-948
13. Jones J., and Clemmons D. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 (1995) 3-34
14. Underwood L.E., Thissen J.P., Lemozy S., Ketelslegers J.M., and Clemmons D.R. Hormonal and nutritional regulation of IGF-1 and its binding proteins. Horm Res 42 (1994) 145-151
15. Smith W.J., Underwood L.E., and Clemmons D.R. Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-1) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 80 (1995) 443-449
16. Ooi G.T., Tseng L.Y., Tran M.Q., and Rechler M.M. Insulin rapidly decreases insulin-like growth factor binding protein-1 gene transcription in streptozotocin- diabetic rats. Mol Endocrinol 6 (1992) 2219-2228
17. Powell D.R., Suwanichkul A., Cubbage M.L., DePaolis L.A., Snuggs M.B., and Lee P.D. Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem 266 (1991) 18868-18876
18. Katz L.E.L., Cohen P., and Rosenfeld R. Clinical significance of IGF binding proteins. Endocrinologist 5 (1995) 36-43
19. Cohen P., Fielder P.J., Hasegawa Y., Frisch H., Giudice L.C., and Rosenfeld R.G. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol (Copenh) 124 (1991) 74-85
20. Lee P.D., Conover C.A., and Powell D.R. Regulation and function of insulin-like growth factor- binding protein-1. Proc Soc Exp Biol Med 204 (1993) 4-29
21. Komninou D., Ayonote A., Richie Jr. J.P., and Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med 228 (2003) 396-405
22. Guler H.P., Zapf J., Schmid C., and Froesch E.R. Insulin-like growth factors I and II in healthy men. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121 (1989) 753-758
23. Palmquist R., Hallmans G., Rinaldi S., Biessy C., Stenling R., Riboli E., et al. Plasma insulin-like growth factor1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 50 (2002) 642-646
24. Giovannucci E., Pollak M.N., Platz E.A., Willett W.C., Stampfer M.J., Majeed N., et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9 (2000) 345-349
25. Ma J., Pollak M.N., Giovannucci E., Chan J.M., Tao Y., Hennekens C.H., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 91 (1999) 620-625
26. Kaaks R., Toniolo P., Akhmedkhanov A., Lukanova A., Biessy C., Dechaud H., et al. Serum C-peptide, insulin-like growth factor (IGF)-1, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92 (2000) 1592-1600
27. Probst-Hensch N.M., Yuan J.M., Stanczyk F.Z., Gao Y.T., Ross R.K., Yu M.C., et al. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 85 (2001) 1695-1699
28. Glass A.R., Kikendall J.W., Sobin L.H., and Bowen P.E. Serum concentrations of insulin-like growth factor 1 in colonic neoplasia. Acta Oncol 33 (1994) 70-71
29. Sandhu M.J., and Dunger D.B. Giovannucci E. Insulin, insulin-like growth factor-1 (IGF-1) IGF binding proteins, their biological interactions, and colorectal cancer. J Natl Cancer Inst 94 (2002) 972-998